Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)

NCT02764736 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.

NCT NCT02764736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)
Lead sponsor
Albert Einstein Healthcare Network
Phase
Not applicable
Overall status
Withdrawn
Start date
March 4, 2016
Completion date
March 22, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

complication of renal dialysis